Commonwealth Equity Services’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
DSCM
Commonwealth Equity Services's FLGT Position: Q2 2024 in Review
Commonwealth Equity Services sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 9,468 shares — an estimated $205K sold.
Commonwealth Equity Services first reported a position in FLGT in Q4 2020 and held it in 14 quarters. The position peaked at $2M in Q2 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.
- Commonwealth Equity Services reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
- Commonwealth Equity Services sold 9,468 Fulgent Genetics shares in Q2 2024, an estimated $205K.
- Commonwealth Equity Services first reported a position in Fulgent Genetics in Q4 2020 and held it in 14 quarters.
- Commonwealth Equity Services's Fulgent Genetics position peaked at $2M in Q2 2021.
- 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.
Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.